List of all submitters

Displaying the submitter´s press releases: Thomas Felzmann

Press releases found: 1

New cancer vaccine developed by the Viennese high tech company Trimed Biotech * AOP Orphan invests in Trimed Biotech: together an individualised treatment concept for cancer shall be developed

20.06.2006 15:02

Submitter: Thomas Felzmann

Press releases found: 1